Lexagene (LXG.V) positions to revolutionize pathogen detection with breakthrough tech

Food safety is major concern for both producers and distributors, so it’s no surprise that the global food safety testing space is expected to be worth $8.0 billion by 2021. Lexagene (LXG.V) seeks to take commercial pathogen detection to a whole new level with its groundbreaking tech and company President, Daryl Rebeck, explains the how it works and what it could mean for investors. See for yourself.
Watch live video from EquityDotGuru on www.twitch.tv

FULL DISCLOSURE: Lexagene Holdings is NOT an EQUITY.GURU client.

Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.

Leave a Reply

Be the First to Comment!

Notify of